Israel Englander’s Avanos Medical AVNS Stock Holding History

Israel Englander’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-40,000	Closed	-$1.46M	–	6768
2021 Q2	$1.46M	Buy	40,000 +20,000	+100%	+$827K	﹤0.01%	4297
2021 Q1	$875K	Buy	+20,000	New	+$939K	﹤0.01%	4343
2020 Q4	–	Sell	-10,000	Closed	-$332	–	5183
2020 Q3	$332	Buy	+10,000	New	+$320K	﹤0.01%	3786
2020 Q1	–	Sell	-20,000	Closed	-$674K	–	3826
2019 Q4	$674K	Buy	+20,000	New	+$724K	﹤0.01%	3197
2019 Q3	–	Sell	-10,000	Closed	-$436K	–	4150
2019 Q2	$436K	Sell	10,000 -140,000	-93%	-$5.99M	﹤0.01%	3326
2019 Q1	$6.4M	Buy	150,000 +50,000	+50%	+$2.24M	0.01%	1586
2018 Q4	$4.48M	Buy	100,000 +50,000	+100%	+$2.62M	0.01%	1663
2018 Q3	$3.42M	Hold	50,000	–	–	﹤0.01%	2063
2018 Q2	$2.86M	Buy	+50,000	New	+$2.64M	﹤0.01%	2166
2017 Q1	–	Sell	-125,000	Closed	-$4.62M	–	3473
2016 Q4	$4.62M	Buy	+125,000	New	+$4.47M	0.01%	1374

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Israel Englander's AVNS Position: Q2 2026 in Review

Israel Englander increased its Avanos Medical (AVNS) stake by 10,927% in Q2 2026, buying an estimated $35.4M and bringing the position to 1,524,553 shares worth $37.9M. The position accounts for 0.01% of the portfolio, ranked #1077.

Israel Englander first reported a position in AVNS in Q4 2014 and has held it in 44 quarters since. 285 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Israel Englander held 1,524,553 shares of Avanos Medical worth $37.9M as of Q2 2026.
Israel Englander bought 1,510,727 Avanos Medical shares in Q2 2026, an estimated $35.4M.
Avanos Medical made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1077 holding.
Israel Englander first reported a position in Avanos Medical in Q4 2014 and has held it in 44 quarters since.
285 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.